Navigation Links
Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
Date:12/12/2007

New York, NY-- The Damon Runyon Cancer Research Foundation named 17 new Damon Runyon Fellows at its November 2007 Scientific Advisory Committee review. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship is specifically intended to encourage the nation's most promising young investigators to pursue careers in cancer research by providing them with independent funding to work on innovative projects. The Damon Runyon Cancer Research Foundation has committed more than $200 million to support the careers of cancer researchers across the United States since the programs inception.

2007 Damon Runyon Fellows

  1. Lu Bai, PhD, with her sponsors Frederick R. Cross, PhD, and Eric D. Siggia, PhD, at The Rockefeller University, New York, New York, is investigating key features in promoter architecture and chromatin structure that govern the transcription of cell cycle-regulated genes, which is an important issue in understanding general cancer mechanisms.

  2. Eric J. Bennett, PhD, with his sponsor J. Wade Harper, PhD, at Harvard Medical School, Boston, Massachusetts, is utilizing rational high-throughput screening to identify new components within the cellular degradation machinery that control the abundance of the prominent tumor suppressor protein, PTEN. The goal is to identify new proteins that cooperate with known cancer causing proteins to initiate oncogenesis.

  3. Jelena Bezbradica, PhD, with her sponsor Ruslan M. Medzhitov, PhD, at Yale University, New Haven, Connecticut, is investigating mechanisms underlying generation of effective T cell immune responses. T cells are responsible for tumor immune surveillance in our body and, hence, can be employed for the generation of novel anti-tumor immunotherapies.

  4. <
    '/>"/>

Contact: Clare M. Cahill
clare.cahill@drcrf.org
212-455-0520
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
4. Protein chatter linked to cancer activation
5. Newly created cancer stem cells could aid breast cancer research
6. Western diet linked to increased risk of colon cancer recurrence
7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
8. Low levels of key protein may indicate pancreatic cancer risk
9. Birth records hold pancreatic cancer clue
10. Many parents at-risk for cancer disclose genetic test results to children
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... Society and the Zoological Society of London has found that ... promiscuity in the animal kingdom is generally a male thing, ... of London (ZSL) have found that, in cheetah society, it’s ... paper in the latest issue of Proceedings of the Royal ...
... copying the body’s own natural "waste disposal" chemistry to mop ... of patients with urea cycle disorders --- most of them ... England Journal of Medicine summarizing a quarter century of experience ... and sodium benzoate, two chemicals the body already makes to ...
... of a smallpox outbreak in the United States, how long ... to start protecting Americans by stimulating an immune response? ... School of Medicine will attempt to answer this question. ... United States in 1971, and the world was declared free ...
Cached Biology News:Philandering female felines forgo fidelity 2An 'elegant' idea proves its worth 25 years later 2Smallpox outbreak: How long would it take for vaccines to protect people? Would it work? 2
(Date:5/22/2015)... May 22, 2015  Actavis plc (NYSE: ACT ... Court of Appeals for the Second Circuit has issued ... requiring the Company to continue distribution of NAMENDA ® ... http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   "While we are ... we intend to continue our strong efforts to convey ...
(Date:5/22/2015)... May 22, 2015 Baylor Research Institute (BRI) ... Translational Genomics Research Institute (TGen) in Phoenix, ... on accelerating early detection and treatments for patients with a ... institutions will lead to new clinical trials and access to ... the gap from bench to bedside across Baylor Scott ...
(Date:5/21/2015)... 2015  Susan Hedstrom, Executive Director of the ... dedicated to supporting research to advance the understanding ... that FPWR has received the organization,s largest donation ... contributed $1 million in support of the organization,s ... "Our gift signifies our tremendous ...
(Date:5/21/2015)... Imagine being able to probe and truly ... Being able to read faces and enjoy genuine invisible ... their thoughts and actions like never before. Use ... unique abstract paintings and video, or, play a completely ... as it creates action, dialog, and outcomes based on ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2
... Robust Amplification of Partially Degraded RNA, ... today announced the launch of its TransPlex(R) ... TransPlex,technology is believed to be the fastest, ... total RNA from a variety of sample ...
... CITY, Mo., Oct. 27 Thomas Reidy, an investor ... developer and,manufacturer of diagnostic products whose American Depository Receipts ... November 3, 2008,at 10:00am EST, to discuss the recent ... Biotech,s current directors., On October 16, 2008, Mr. ...
... - Teva Announces Sufficient Funds to Complete Acquisition, ... Industries Ltd. (Nasdaq: TEVA ) and Barr,Pharmaceuticals, Inc. ... its,syndicate of lending banks, arranged by Bank of America, ... them to remain in place,following Barr,s acquisition by Teva., ...
Cached Biology Technology:Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples 2Investor Call Scheduled to Discuss Ouster Proposal of Trinity Biotech Directors 2Teva and Barr Provide Update on Acquisition 2Teva and Barr Provide Update on Acquisition 3Teva and Barr Provide Update on Acquisition 4Teva and Barr Provide Update on Acquisition 5
Latanoprost EIA Antiserum EIAs neutrophils antisera enzyme immunoassays reagents...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Phospho-SEK1/MKK4 (Thr261) Antibody...
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Biology Products: